Fibroblast activation protein-targeted radiopharmaceuticals: Recent trends in cancer diagnosis
Abstract
Fibroblast activation protein (FAP), widely overexpressed in the tumor stroma of various cancers, has emerged as a promising target for cancer imaging. Radiopharmaceuticals designed to target FAP offer significantly improved tumor-to-background contrast compared to traditional imaging agents, thereby enhancing the precision of cancer detection. This review summarizes recent advancements in FAP-targeted diagnosis radiopharmaceuticals, highlighting their advantages and future potential.
Fields of Study & Subjects
Peptidase Inhibition and Analysis
Click Chemistry and Applications
Histone Deacetylase Inhibitors Research
Publication details
- Journal / source
- Journal of Clinical Imaging Science
- Publisher
- Scientific Scholar
- Volume
- 16
- Pages
- 1–1
- Publication date
- 2 January 2026
- Language
- EN